Novo Nordisk A/s
Clinical trials sponsored by Novo Nordisk A/s, explained in plain language.
-
Obesity drug study ends early, but Real-World data may still help
Disease control TerminatedThis study aimed to see how well semaglutide works for weight loss in everyday medical practice, outside of a strict research setting. It involved 100 adults with obesity who were already planning to take the drug. The study was stopped early, so results are limited, but it may s…
Sponsor: Novo Nordisk A/S • Aim: Disease control
Last updated Jun 27, 2026 12:24 UTC
-
Why do some kids respond to growth hormone? scientists look to genetics
Knowledge-focused TerminatedThis study looked at children with idiopathic short stature (short stature with no known cause) who had already received growth hormone therapy for at least a year. Researchers compared the genetic profiles of those who responded well to treatment versus those who did not. The go…
Sponsor: Novo Nordisk A/S • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:03 UTC